Your browser doesn't support javascript.
loading
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.
Gleeson, M; Counsell, N; Cunningham, D; Chadwick, N; Lawrie, A; Hawkes, E A; McMillan, A; Ardeshna, K M; Jack, A; Smith, P; Mouncey, P; Pocock, C; Radford, J A; Davies, J; Turner, D; Kruger, A; Johnson, P; Gambell, J; Linch, D.
Affiliation
  • Gleeson M; Department of Medicine, The Royal Marsden Hospital, London and Surrey, UK.
  • Counsell N; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Cunningham D; Department of Medicine, The Royal Marsden Hospital, London and Surrey, UK;. Electronic address: david.cunningham@rmh.nhs.uk.
  • Chadwick N; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Lawrie A; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Hawkes EA; Department of Oncology and Clinical Haematology, Austin Health, Heidelberg, Melbourne, Australia;; Department of Medical Oncology, Eastern Health, Melbourne, Australia.
  • McMillan A; Department of Haematology, Nottingham City Hospital, Nottingham, UK.
  • Ardeshna KM; Department of Haematology, University College London, London, UK;; Department of Haematology, Mount Vernon Cancer Centre, Northwood, UK.
  • Jack A; HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Smith P; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Mouncey P; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Pocock C; Department of Haematology, East Kent Hospitals, Canterbury, UK.
  • Radford JA; The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Davies J; Department of Haematology, Western General Hospital, Edinburgh, UK.
  • Turner D; Department of Haematology, Torbay Hospital, Torquay, UK.
  • Kruger A; Department of Haematology, Royal Cornwall Hospital, Truro, UK.
  • Johnson P; Cancer Research UK Centre, Southampton, UK.
  • Gambell J; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.
  • Linch D; Department of Haematology, University College London, London, UK.
Ann Oncol ; 28(10): 2511-2516, 2017 Oct 01.
Article de En | MEDLINE | ID: mdl-28961838
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Lymphome B diffus à grandes cellules / Tumeurs du système nerveux central Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Lymphome B diffus à grandes cellules / Tumeurs du système nerveux central Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Royaume-Uni